id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-D-3759-0011,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry; Availability,Notice,Notice of Availability,2019-12-20T05:00:00Z,2019,12,2019-12-20T05:00:00Z,,2019-12-20T13:50:21Z,2019-27520,0,0,090000648423ff4d
FDA-2018-D-3759-0012,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry,Other,Guidance,2019-12-19T05:00:00Z,2019,12,2019-12-19T05:00:00Z,,2024-11-12T23:14:53Z,,1,0,09000064842403d5
FDA-2018-D-3759-0004,FDA,FDA-2018-D-3759,02 Reference 2 The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital,Supporting & Related Material,Background Material,2018-10-30T04:00:00Z,2018,10,,,2018-10-30T14:03:27Z,,0,0,0900006483869335
FDA-2018-D-3759-0003,FDA,FDA-2018-D-3759,01 Reference 1 Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock,Supporting & Related Material,Background Material,2018-10-30T04:00:00Z,2018,10,,,2018-10-30T14:02:38Z,,0,0,0900006483869334
FDA-2018-D-3759-0002,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion Draft Guidance for Industry,Other,Guidance,2018-10-30T04:00:00Z,2018,10,2018-10-30T04:00:00Z,2019-01-29T04:59:59Z,2024-11-12T22:48:46Z,,1,0,0900006483869332
FDA-2018-D-3759-0005,FDA,FDA-2018-D-3759,03 Reference 3 Dried plasma state of the science and recent developments,Supporting & Related Material,Background Material,2018-10-30T04:00:00Z,2018,10,,,2018-10-30T14:04:09Z,,0,0,0900006483869336
FDA-2018-D-3759-0006,FDA,FDA-2018-D-3759,04 Reference 4 The Plasma Wars a History,Supporting & Related Material,Background Material,2018-10-30T04:00:00Z,2018,10,,,2018-10-30T14:05:33Z,,0,0,0900006483869337
FDA-2018-D-3759-0001,FDA,FDA-2018-D-3759,Considerations for the Development of Dried Plasma Products Intended for Transfusion; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2018-10-30T04:00:00Z,2018,10,2018-10-30T04:00:00Z,2019-01-29T04:59:59Z,2024-11-12T22:48:34Z,2018-23637,1,0,0900006483868432